Hard-earned insights from Cytiva’s diagnostics lead on building scalable, regulator-ready quantitative tests
Quantification is the future of lateral flow. Here’s how to make it work.
Quantitative formats are fast becoming the norm in respiratory panels, chronic disease monitoring, and decentralized trials—but getting them right takes more than just adding a reader. In this ALFC Sponsor Series episode of Expert Insights, Klaus Hochleitner, Ph.D., of Cytiva joins DCN Dx’s Mitzi Rettinger and Pat Vaughan, Ph.D., to unpack what truly makes or breaks a quantitative lateral flow test.
Klaus draws on years of hands-on experience to highlight where developers go wrong, what they should prioritize early, and how choices like membrane type, conjugate performance, and reader integration shape long-term scalability. He also previews his upcoming lunch & learn session at ALFC 2025: “Considerations in the Development of Quantitative Lateral Flow Tests.”
Learn more about ALFC 2025 here.
